BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22370646)

  • 1. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
    Psallidas I; Stathopoulos GT; Maniatis NA; Magkouta S; Moschos C; Karabela SP; Kollintza A; Simoes DC; Kardara M; Vassiliou S; Papiris SA; Roussos C; Kalomenidis I
    Oncogene; 2013 Jan; 32(4):528-35. PubMed ID: 22370646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion.
    Magkouta S; Pappas A; Moschos C; Vazakidou ME; Psarra K; Kalomenidis I
    Oncotarget; 2016 Apr; 7(15):20249-59. PubMed ID: 26959120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells mediate malignant pleural effusion formation.
    Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
    J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.
    Cui R; Takahashi F; Ohashi R; Yoshioka M; Gu T; Tajima K; Unnoura T; Iwakami S; Hirama M; Ishiwata T; Iwase A; Takahashi K
    Lung Cancer; 2009 Mar; 63(3):368-74. PubMed ID: 18752867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid is effective against experimental malignant pleural effusion.
    Stathopoulos GT; Moschos C; Loutrari H; Kollintza A; Psallidas I; Karabela S; Magkouta S; Zhou Z; Papiris SA; Roussos C; Kalomenidis I
    Am J Respir Crit Care Med; 2008 Jul; 178(1):50-9. PubMed ID: 18388351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutical effects of pleural injecting recombinant human endostain to 
malignant pleural effusion nude mice model].
    Zhou M; Li M; Yang H; Hu C
    Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.
    Xie SL; Yang MH; Chen K; Huang H; Zhao XW; Zang YS; Li B
    Cell Biochem Biophys; 2015 Apr; 71(3):1325-33. PubMed ID: 25413961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sulindac analogue is effective against malignant pleural effusion in mice.
    Moschos C; Psallidas I; Cottin T; Kollintza A; Papiris S; Roussos C; Stathopoulos GT; Giannis A; Kalomenidis I
    Lung Cancer; 2011 Aug; 73(2):171-5. PubMed ID: 21227533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian target of rapamycin (mTOR) inhibition does not prevent lung adenocarcinoma-induced malignant pleural effusion.
    Vazakidou ME; Magkouta S; Moschos C; Kalomenidis I
    Respirology; 2014 Feb; 19(2):290-292. PubMed ID: 23819792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine is effective for the malignant pleural effusion associated with lung cancer in mice.
    Cui R; Yoshioka M; Takahashi F; Ishida H; Iwakami S; Takahashi K
    Anticancer Res; 2008; 28(3A):1633-9. PubMed ID: 18630520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Endostar combined with angiopoietin-2 inhibitor on malignant pleural effusion in mice.
    Fang SC; Zhang HT; Hu HD; Wang CY; Zhang YM
    Med Oncol; 2015 Jan; 32(1):410. PubMed ID: 25479942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.
    Stathopoulos GT; Zhu Z; Everhart MB; Kalomenidis I; Lawson WE; Bilaceroglu S; Peterson TE; Mitchell D; Yull FE; Light RW; Blackwell TS
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):142-50. PubMed ID: 16210694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
    Psallidas I; Karabela SP; Moschos C; Sherrill TP; Kollintza A; Magkouta S; Theodoropoulou P; Roussos C; Blackwell TS; Kalomenidis I; Stathopoulos GT
    Mol Cancer; 2010 Mar; 9():56. PubMed ID: 20219102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant pleural effusion: tumor-host interactions unleashed.
    Stathopoulos GT; Kalomenidis I
    Am J Respir Crit Care Med; 2012 Sep; 186(6):487-92. PubMed ID: 22652027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of malignant-associated pleural effusion on endothelial viability, motility and angiogenesis in lung cancer.
    Changchien CY; Chen Y; Chang HH; Chang SY; Tsai WC; Tsai HC; Wang CY; Lee HS; Tsai CL
    Cancer Sci; 2020 Oct; 111(10):3747-3758. PubMed ID: 32706142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of recombinant human endostatin adenovirus in a mouse model of malignant pleural effusion.
    Fang F; Chen P; Wu X; Yang L; Yang X; Xi ZX; Zhou BW; Zhou XK; Qian ZY; Xiao B; Wei YQ
    J Cancer Res Clin Oncol; 2009 Sep; 135(9):1149-57. PubMed ID: 19219619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
    Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
    Yeh HH; Lai WW; Chen HH; Liu HS; Su WC
    Oncogene; 2006 Jul; 25(31):4300-9. PubMed ID: 16518408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.